APO Research
Talk to an analyst

APO RESEARCH · REPORT

Maternal Pertussis Vaccine for Newborn Protection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Maternal Pertussis Vaccine for Newborn Protection Industry Growth and Trends Forecast to 2032

27 December 202590 pages

Choose your research edition.

Industry ResearchMaternal Pertussis Vaccine for Newborn Protection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Maternal Pertussis Vaccine for Newborn Protection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Maternal Pertussis Vaccine for Newborn Protection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Maternal Pertussis Vaccine for Newborn Protection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Maternal Pertussis Vaccine for Newborn Protection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Maternal Pertussis Vaccine for Newborn Protection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Maternal Pertussis Vaccine for Newborn Protection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Maternal Pertussis Vaccine for Newborn Protection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Maternal Pertussis Vaccine for Newborn Protection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Maternal Pertussis Vaccine for Newborn Protection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Maternal Pertussis Vaccine for Newborn Protection market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Maternal Pertussis Vaccine for Newborn Protection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Maternal Pertussis Vaccine for Newborn Protection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Maternal Pertussis Vaccine for Newborn Protection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Maternal Pertussis Vaccine for Newborn Protection Market by Company

Zhifei Biological

Walvax

Minhai Biological

GlaxoSmithKline

Sanofi Pasteur

Intravacc

Maternal Pertussis Vaccine for Newborn Protection Segment by Type

Whole-cell Pertussis Vaccine

Acellular Pertussis Vaccine

Maternal Pertussis Vaccine for Newborn Protection Segment by Application

Hospital

Centers for Disease Control and Prevention

Others

Maternal Pertussis Vaccine for Newborn Protection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Maternal Pertussis Vaccine for Newborn Protection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Whole-cell Pertussis Vaccine Table 2. Major Company of Acellular Pertussis Vaccine Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type (2021-2026) Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 10. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type (2027-2032) Table 13. Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 15. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 17. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 21. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (US$ Million) Table 24. Maternal Pertussis Vaccine for Newborn Protection Industry Trends Table 25. Maternal Pertussis Vaccine for Newborn Protection Industry Drivers Table 26. Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges Table 27. Maternal Pertussis Vaccine for Newborn Protection Industry Restraints Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company (2021-2026) Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Company (2021-2026) & (Units) Table 31. Global Maternal Pertussis Vaccine for Newborn Protection Sales Share by Company (2021-2026) Table 32. Global Maternal Pertussis Vaccine for Newborn Protection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Maternal Pertussis Vaccine for Newborn Protection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Maternal Pertussis Vaccine for Newborn Protection Major Company Production Sites and Headquarters Table 35. Global Maternal Pertussis Vaccine for Newborn Protection Company, Product Type & Application Table 36. Global Maternal Pertussis Vaccine for Newborn Protection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Maternal Pertussis Vaccine for Newborn Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026) & (Units) Table 41. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Region (2021-2026) Table 44. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2027-2032) & (Units) Table 46. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Region (2027-2032) Table 49. Global Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application (2021-2026) Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application (2027-2032) Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 62. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 64. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 68. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (US$ Million) Table 71. Zhifei Biological Company Information Table 72. Zhifei Biological Business Overview Table 73. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 75. Zhifei Biological Recent Development Table 76. Walvax Company Information Table 77. Walvax Business Overview Table 78. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 80. Walvax Recent Development Table 81. Minhai Biological Company Information Table 82. Minhai Biological Business Overview Table 83. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 85. Minhai Biological Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Sanofi Pasteur Company Information Table 92. Sanofi Pasteur Business Overview Table 93. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 95. Sanofi Pasteur Recent Development Table 96. Intravacc Company Information Table 97. Intravacc Business Overview Table 98. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 100. Intravacc Recent Development Table 101. North America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 102. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 103. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026) Table 104. North America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Units) Table 105. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Country (2027-2032) Table 106. North America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Maternal Pertussis Vaccine for Newborn Protection Market Share by Country (2021-2026) Table 109. North America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Country (2027-2032) Table 111. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 112. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 113. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026) Table 114. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Units) Table 115. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Maternal Pertussis Vaccine for Newborn Protection Market Share by Country (2021-2026) Table 119. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 123. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Units) Table 125. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Share by Country (2021-2026) Table 129. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Country (2027-2032) Table 131. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 132. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 133. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026) Table 134. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Units) Table 135. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Share by Country (2021-2026) Table 139. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 143. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Units) Table 145. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Share by Country (2021-2026) Table 149. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Maternal Pertussis Vaccine for Newborn Protection Distributors List Table 154. Maternal Pertussis Vaccine for Newborn Protection Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Maternal Pertussis Vaccine for Newborn Protection Image Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (2021-2032) & (US$ Million) Figure 4. Global Maternal Pertussis Vaccine for Newborn Protection Sales (2021-2032) & (Units) Figure 5. Whole-cell Pertussis Vaccine Image Figure 6. Global Whole-cell Pertussis Vaccine Sales YoY Growth (2021-2032) & (Units) Figure 7. Acellular Pertussis Vaccine Image Figure 8. Global Acellular Pertussis Vaccine Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type 2025 VS 2032 Figure 11. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type in 2025 Figure 12. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type in 2025 Figure 13. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 25. Centers for Disease Control and Prevention Image Figure 26. Global Centers for Disease Control and Prevention Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application 2025 VS 2032 Figure 31. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application in 2025 Figure 32. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application in 2025 Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share in Value by Application in 2025 Figure 41. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Maternal Pertussis Vaccine for Newborn Protection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Maternal Pertussis Vaccine for Newborn Protection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Maternal Pertussis Vaccine for Newborn Protection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-cell Pertussis Vaccine
  • Acellular Pertussis Vaccine
Applications
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Companies covered
  • Zhifei Biological
  • Walvax
  • Minhai Biological
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Intravacc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Maternal Pertussis Vaccine for Newborn Protection Market by Type
  6. 1.3.1 Whole-cell Pertussis Vaccine
  7. 1.3.2 Acellular Pertussis Vaccine
  8. 1.4 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  9. 1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
  2. 2.2 Maternal Pertussis Vaccine for Newborn Protection Industry Drivers
  3. 2.3 Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges
  4. 2.4 Maternal Pertussis Vaccine for Newborn Protection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2026)
  2. 3.2 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Sales (2021-2026)
  3. 3.3 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Price (2021-2026)
  4. 3.4 Global Maternal Pertussis Vaccine for Newborn Protection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Maternal Pertussis Vaccine for Newborn Protection Major Company Production Sites & Headquarters
  6. 3.6 Global Maternal Pertussis Vaccine for Newborn Protection Company, Product Type & Application
  7. 3.7 Global Maternal Pertussis Vaccine for Newborn Protection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Maternal Pertussis Vaccine for Newborn Protection Tier 1, Tier 2, and Tier 3
4 Maternal Pertussis Vaccine for Newborn Protection Regional Status and Outlook
  1. 4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size by Region
  3. 4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Region
  7. 4.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Maternal Pertussis Vaccine for Newborn Protection by Application
  1. 5.1 Maternal Pertussis Vaccine for Newborn Protection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Centers for Disease Control and Prevention
  4. 5.1.3 Others
  5. 5.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhifei Biological
  2. 6.1.1 Zhifei Biological Company Information
  3. 6.1.2 Zhifei Biological Business Overview
  4. 6.1.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  6. 6.1.5 Zhifei Biological Recent Developments
  7. 6.2 Walvax
  8. 6.2.1 Walvax Company Information
  9. 6.2.2 Walvax Business Overview
  10. 6.2.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  12. 6.2.5 Walvax Recent Developments
  13. 6.3 Minhai Biological
  14. 6.3.1 Minhai Biological Company Information
  15. 6.3.2 Minhai Biological Business Overview
  16. 6.3.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  18. 6.3.5 Minhai Biological Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Sanofi Pasteur
  26. 6.5.1 Sanofi Pasteur Company Information
  27. 6.5.2 Sanofi Pasteur Business Overview
  28. 6.5.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  30. 6.5.5 Sanofi Pasteur Recent Developments
  31. 6.6 Intravacc
  32. 6.6.1 Intravacc Company Information
  33. 6.6.2 Intravacc Business Overview
  34. 6.6.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  36. 6.6.5 Intravacc Recent Developments
7 North America by Country
  1. 7.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
  2. 7.1.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
  4. 7.1.3 North America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  6. 7.2.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026)
  8. 7.2.3 North America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country
  2. 8.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
  4. 8.1.3 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  6. 8.2.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country
  2. 9.1.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  6. 9.2.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
  2. 10.1.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
  4. 10.1.3 South America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  6. 10.2.1 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026)
  8. 10.2.3 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country
  2. 11.1.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  6. 11.2.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Maternal Pertussis Vaccine for Newborn Protection Value Chain Analysis
  2. 12.1.1 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
  7. 12.2 Maternal Pertussis Vaccine for Newborn Protection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
  10. 12.2.3 Maternal Pertussis Vaccine for Newborn Protection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst